Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057781 · ClinicalTrials.gov registry record · NA
Pain and Neck Dysfunction Following Dry Needling With and Without Intramuscular Electrical Stimulus.
A NA study, sponsored by University of Mary Hardin-Baylor.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04057781: Completed NA study, sponsored by University of Mary Hardin-Baylor.
NCT04057781 is a NA study that has completed, run by University of Mary Hardin-Baylor. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04057781, a NA study, has completed, sponsored by University of Mary Hardin-Baylor.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Participants will be 18-59 years old who are recruited through a convenience sample from the UMHB/Belton community. There will be a randomized control trial consisting of three groups. Each participant will be assigned based on their order of entry to the study group assignment and then randomly organized via computer generation into 3 groups of 20 participants including a control group, a dry needling group (DN), and a dry needling E-stim group (DN-ES), resulting in approximately 60 total participants. Participants in the DN and DN-ES groups will be treated four times; at weeks 0, 2, 4 and 6 of the study. Data will be collected at weeks 4, 6 and 12 in all groups.
Primary Outcome
Between group difference in within group pain changes. The NPRS is an 11 point (0-10) scale with 10 meaning "the worst imaginable pain" and 0 meaning "no pain". It is reported as a whole number out of 10, and multiple ratings, i.e. worst, average, and best pain scores over the past 48 hours, can be averaged and reported as a single score.
Interventions
- PROCEDURE Dry Needling (DN)
- PROCEDURE Dry needling with Intramuscular electrical stimulation (DNES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2020-01-01 |
| Phase | NA |
What the finished NCT04057781 record still lists
NCT04057781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Dry Needling (DN) is the first listed.
NCT04057781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04057781 about?
NCT04057781 is a clinical study titled "Pain and Neck Dysfunction Following Dry Needling With and Without Intramuscular Electrical Stimulus.". Participants will be 18-59 years old who are recruited through a convenience sample from the UMHB/Belton community. There will be a randomized control trial consisting of three groups. Each participant will be assigned based on their order of entry to the study group assignment and then randomly org...
What is the current status of trial NCT04057781?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2019-09-01. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT04057781?
The interventions under investigation include: Dry Needling (DN) (PROCEDURE), Dry needling with Intramuscular electrical stimulation (DNES) (PROCEDURE).
Who is sponsoring clinical trial NCT04057781?
This trial is sponsored by University of Mary Hardin-Baylor, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04057781's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI